Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,788Revenue $M2,641Net Margin (%)5.1Altman Z-Score1.4
Enterprise Value $M13,091EPS $-0.6Operating Margin %8.8Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-7.2Higher ROA y-yN
Price/Book5.610-y EBITDA Growth Rate %--Quick Ratio1.2Cash flow > EarningsN
Price/Sales3.55-y EBITDA Growth Rate %--Current Ratio1.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-49.8ROA % (ttm)1.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)8.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M339ROIC % (ttm)10.3Gross Margin Increase y-yN

Gurus Latest Trades with IMS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IMSVanguard Health Care Fund 2014-12-31 Add0.15%$23.88 - $26.33
($25.23)
$ 28.9115%Add 25.80%11,995,380
IMSFirst Eagle Investment 2014-12-31 Sold Out -0.04%$23.88 - $26.33
($25.23)
$ 28.9115%Sold Out0
IMSVanguard Health Care Fund 2014-06-30 Buy 0.65%$22.83 - $25.45
($24.01)
$ 28.9120%New holding9,535,580
IMSFirst Eagle Investment 2014-06-30 Buy 0.04%$22.83 - $25.45
($24.01)
$ 28.9120%New holding606,452
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IMS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


IMS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CPP Investment Board Private H10% Owner 2015-05-12Sell30,554,584$26.688.36view
Green Equity Investors V, L.P.Director 2015-05-12Sell6,278,340$26.787.95view
DANHAKL JOHN GDirector 2015-05-12Sell6,278,340$26.787.95view
TPG Group Holdings (SBS) Advis10% Owner 2015-05-12Sell36,414,368$26.787.95view
Linn Stefan CSee Remarks 2014-11-03Buy4,000$23.8221.37view
CPP Investment Board Private H10% Owner 2014-04-09Sell11,990,976$19.151.36view
TPG Group Holdings (SBS) Advis10% Owner 2014-04-09Sell14,290,613$19.151.36view
Green Equity Investors V, L.P.Director 2014-04-09Sell2,463,899$2044.55view
DANHAKL JOHN GDirector 2014-04-09Sell2,463,899$2044.55view
Green Equity Investors V, L.P.Director 2014-04-09Sell2,463,899$2044.55view

Press Releases about IMS :

Quarterly/Annual Reports about IMS:

News about IMS:

Articles On GuruFocus.com
Weekly Insider Sells Highlight: FSL, IMS, EA, PANW May 17 2015 
Weekly Insider Sells Highlight: BPZ, IMS, TDG, GIS, UNP Apr 14 2014 

More From Other Websites
IMS HEALTH HOLDINGS, INC. Financials May 22 2015
Weekly Insider Sells Highlight: FSL, IMS, EA, PANW May 17 2015
IMS HEALTH HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report May 15 2015
IMS Health Announces Closing of Secondary Public Offering and Repurchase of Common Stock May 12 2015
IMS Health Announces Closing of Secondary Public Offering and Repurchase of Common Stock May 12 2015
IMS HEALTH HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation... May 12 2015
Cancer drug spending hit $100 billion in 2014. Here’s why it’ll soon be much higher May 08 2015
IMS Health Announces Pricing of Secondary Public Offering and Repurchase of Common Stock May 06 2015
IMS Health Announces Pricing of Secondary Public Offering and Repurchase of Common Stock May 06 2015
IMS Health Acquires Dataline Software, Extending Real-World Evidence Technology Platform and... May 06 2015
IMS Health Acquires Dataline Software, Extending Real-World Evidence Technology Platform and... May 06 2015
IMS Health Acquires Dataline Software, Extending Real-World Evidence Technology Platform and... May 06 2015
IMS Health Finds Global Cancer Drug Spending Crossed $100 Billion Threshold in 2014 May 06 2015
IMS Health Finds Global Cancer Drug Spending Crossed $100 Billion Threshold in 2014 May 05 2015
The Cancer Drug Market Just Hit $100 Billion And Could Jump 50% In Four Years May 05 2015
Global cancer drug spending hits $100 billion in 2014 - IMS Health May 05 2015
Global cancer drug spending hits $100 billion in 2014-IMS Health May 05 2015
Global cancer drug spending hits $100 billion in 2014-IMS Health May 05 2015
IMS Health Announces Launch of Secondary Public Offering and Repurchase of Common Stock May 04 2015
IMS Health Announces Launch of Secondary Public Offering and Repurchase $300M Common Stock May 04 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK